![]() |
|
| Medical Subject Headings | |
Links are to the MeSH Browser.
A2 (Musculoskeletal System)
Palate, Hard
Scaphoid Bone
Zygapophyseal Joint
A11 (Cells)
Adherens Junctions
Caveolae
Cell Membrane Structures
Cell Nucleus Structures
Cell Surface Extensions
Cell-Matrix Junctions
Cellular Structures
Chromosome Structures
Chromosomes, Artificial
Chromosomes, Bacterial Artificial
Chromosomes, Human Artificial
Chromosomes, Mammalian Artificial
Clathrin-Coated Vesicles
COP-Coated Vesicles
Cytoplasmic Structures
Cytoplasmic Vesicles
Euchromatin
Focal Adhesions
Hemidesmosomes
Hepatocytes
Membrane Microdomains
Microtubule-Organizing Center
Myeloid Cells
Myeloid Progenitor Cells
Nuclear Pore
Secretory Vesicles
Stress Fibers
trans-Golgi Network
Transport Vesicles
A14 (Stomatognathic System)
A15 (Hemic and Immune Systems)
Myeloid Cells
Myeloid Progenitor Cells
B1 (Invertebrates)
Animals, Outbred Strains
Cryptosporidiidae
Cyclospora
Eimeriida
Eimeriidae
Enterocytozoon
Microsporidia, Unclassified
Pleistophora
Sarcocystidae
Vittaforma
B2 (Vertebrates)
Animals, Outbred Strains
Sea Bream
B3 (Bacteria)
Chlamydia muridarum
Chlamydophila
Enterobacter aerogenes
B4 (Viruses)
Herpesvirus 4, Equid
Jaagsiekte Sheep Retrovirus
Transfusion-Transmitted Virus
B5 (Algae and Fungi)
C1 (Bacterial Infections and Mycoses)
Chlamydophila Infections
Communicable Diseases, Emerging
C3 (Parasitic Diseases)
C4 (Neoplasms)
Carcinoma, Pancreatic Ductal
Multicystic Dysplastic Kidney
C10 (Nervous System Diseases)
C11 (Eye Diseases)
C12 (Urologic and Male Genital Diseases)
C13 (Female Genital Diseases and Pregnancy Complications)
C14 (Cardiovascular Diseases)
Aortic Stenosis, Supravalvular
Discrete Subaortic Stenosis
C15 (Hemic and Lymphatic Diseases)
C16 (Neonatal Diseases and Abnormalities)
Hermanski-Pudlak Syndrome
Multicystic Dysplastic Kidney
C17 (Skin and Connective Tissue Diseases)
C18 (Nutritional and Metabolic Diseases)
Hermanski-Pudlak Syndrome
Hyperammonemia
C21 (Disorders of Environmental Origin)
C23 (Pathological Conditions, Signs and Symptoms)
D2 (Organic Chemicals)
D3 (Heterocyclic Compounds)
D8 (Enzymes, Coenzymes, and Enzyme Inhibitors)
Cyclophilin A
Cyclophilins
DNA, Catalytic
Tacrolimus Binding Protein 1A
Tacrolimus Binding Proteins
D12 (Amino Acids, Peptides, and Proteins)
alpha-Defensins
Amino Acids, Neutral
Antifreeze Proteins
Antifreeze Proteins, Type I
Antifreeze Proteins, Type II
Antifreeze Proteins, Type III
Antifreeze Proteins, Type IV
Antimicrobial Cationic Peptides
beta-Defensins
Caveolins
CCAAT-Binding Factor
CCAAT-Enhancer-Binding Protein-alpha
CCAAT-Enhancer-Binding Protein-beta
CCAAT-Enhancer-Binding Proteins
CD40 Ligand
Complementarity Determining Regions
Cyclophilins
Defensins
Euchromatin
Protein Sorting Signals
Protein Subunits
Receptors, Adrenergic, beta-3
Receptors, Interleukin-8A
Receptors, Interleukin-8B
Tacrolimus Binding Protein 1A
Tacrolimus Binding Proteins
Vaccines, Edible
Vaccines, Virosome
D13 (Nucleic Acids, Nucleotides, and Nucleosides)
Chromosomes, Artificial
Chromosomes, Bacterial Artificial
Chromosomes, Human Artificial
Chromosomes, Mammalian Artificial
DNA, Catalytic
DNA, Intergenic
DNA, Ribosomal Spacer
RNA Splice Sites
RNA, Messenger, Stored
RNA, Untranslated
D24 (Immunologic and Biological Factors)
alpha-Defensins
Anthrax Vaccines
Antimicrobial Cationic Peptides
beta-Defensins
CD40 Ligand
Cholera Vaccines
Complementarity Determining Regions
Cyclophilins
Cytomegalovirus Vaccines
Defensins
Diphtheria-Tetanus Vaccine
Diphtheria-Tetanus-acellular Pertussis Vaccines
Escherichia coli Vaccines
Hepatitis A Vaccines
Herpes Simplex Virus Vaccines
Herpesvirus Vaccines
Japanese Encephalitis Vaccines
Lyme Disease Vaccines
Marek Disease Vaccines
Measles-Mumps-Rubella Vaccine
Meningococcal Vaccines
Parainfluenza Vaccines
Pneumococcal Vaccines
Poliovirus Vaccines
Pseudorabies Vaccines
Receptors, Interleukin-8A
Respiratory Syncytial Virus Vaccines
Rotavirus Vaccines
Salmonella Vaccines
Shiga Toxin
Shiga Toxins
Shiga-Like Toxin I
Shiga-Like Toxin II
Shigella Vaccines
Streptococcal Vaccines
Tacrolimus Binding Protein 1A
Tacrolimus Binding Proteins
Vaccines, Acellular
Vaccines, Contraceptive
Vaccines, Edible
Vaccines, Marker
Vaccines, Subunit
Vaccines, Virosome
Yellow Fever Vaccine
D26 (Specialty Chemicals and Products)
D27 (Chemical Actions and Uses)
E1 (Diagnosis)
Electrophysiologic Techniques, Cardiac
Imaging, Three-Dimensional
Local Lymph Node Assay
Sentinel Lymph Node Biopsy
E2 (Therapeutics)
Advanced Cardiac Life Support
Antiretroviral Therapy, Highly Active
Balloon Occlusion
Liquid Ventilation
E4 (Surgical Procedures, Operative)
E5 (Investigative Techniques)
Acute Toxicity Tests
Branched DNA Signal Amplification Assay
Endpoint Determination
Glasgow Outcome Scale
Ligase Chain Reaction
Models, Animal
Nuclease Protection Assays
Nucleic Acid Amplification Techniques
Parasitic Sensitivity Tests
Protein Footprinting
Radiation Hybrid Mapping
Ribotyping
Self-Sustained Sequence Replication
Skin Irritancy Tests
Spectrometry, Mass, Electrospray Ionization
Xenograft Model Antitumor Assays
E7 (Equipment and Supplies)
F1 (Behavior and Behavior Mechanisms)
F2 (Psychological Phenomena and Processes)
G1 (Biological Sciences)
Genomics
Parasitic Sensitivity Tests
G2 (Health Occupations)
G4 (Biological Phenomena, Cell Phenomena, and Immunity)
Anoikis
Transplantation Tolerance
G5 (Genetics)
Allelic Imbalance
DNA, Intergenic
Gene Order
Gene Transfer, Horizontal
Protein Sorting Signals
RNA Splice Sites
G6 (Biochemical Phenomena, Metabolism, and Nutrition)
Active Transport, Cell Nucleus
Complementarity Determining Regions
DNA, Intergenic
Protein Sorting Signals
Protein Transport
Quantitative Structure-Activity Relationship
RNA Splice Sites
G7 (Physiological Processes)
G9 (Circulatory and Respiratory Physiology)
G12 (Chemical and Pharmacologic Phenomena)
Quantitative Structure-Activity Relationship
H1 (Physical Sciences)
Animal Use Alternatives
Quantitative Structure-Activity Relationship
Virosomes
I1 (Social Sciences)
K1 (Humanities)
History of Medicine, 21st Cent.
L1 (Information Science)
N4 (Health Services Administration)
Glasgow Outcome Scale
Management Service Organizations
N5 (Health Care Quality, Access, and Evaluation)
Last updated: 22 January 2001
First published: 22 January 2001
Metadata| Permanence level: Permanence Not Guaranteed